The Bordetella pertussis virulence factor P.69 pertactin retains its immunological properties after overproduction in Escherichia coli

This publication has 19 references indexed in Scilit:

• Bordetella pertussisProtein Pertactin Induces Type‐Specific Antibodies: One Possible Explanation for the Emergence of Antigenic Variants?
  The Journal of Infectious Diseases, 2003
• Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity
  Microbiology, 2001
• Goat-Associated Q Fever: A New Disease in Newfoundland
  Emerging Infectious Diseases, 2001
• Bordetella pertussis Infection: Pathogenesis, Diagnosis, Management, and the Role of Protective Immunity
  European Journal of Clinical Microbiology & Infectious Diseases, 2000
• Overview of Recent Clinical Trials of Acellular Pertussis Vaccines
  Biologicals, 1999
• Temporal Trends in the Population Structure ofBordetella pertussisduring 1949–1996 in a Highly Vaccinated Population
  The Journal of Infectious Diseases, 1999
• A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
  Vaccine, 1998
• Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis
  Vaccine, 1998
• Polymorphism in the Bordetella pertussis Virulence Factors P.69/Pertactin and Pertussis Toxin in The Netherlands: Temporal Trends and Evidence for Vaccine-Driven Evolution
  Infection and Immunity, 1998
• Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.
  Proceedings of the National Academy of Sciences, 1991